Skip to content
Financial ServicesHealthcare

EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Healthcare

How does EU Directive (EU) 2018/1673 on combating money laundering by criminal law apply to healthcare?

Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. EU Directive (EU) 2018/1673 on combating money laundering by criminal law provides 20 controls across 16 domains that healthcare organisations map onto their sector obligations, so one control satisfies several requirements instead of being evidenced separately for each.

Why healthcare regulators care about EU Directive (EU) 2018/1673 on combating money laundering by criminal law

Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. Patient data protection, clinical trial integrity, and medical device safety demand rigorous governance frameworks.

Healthcare organisations typically navigate HIPAA, FDA regulations, GxP requirements, and regional data protection laws simultaneously. A structured compliance framework helps consolidate these overlapping obligations into a manageable programme.

EU Directive (EU) 2018/1673 on combating money laundering by criminal law provides 20 controls organised across 16 domains that can be mapped to healthcare-specific regulatory requirements. This structured approach helps organisations avoid compliance gaps while reducing the overhead of managing multiple overlapping obligations.

Where healthcare implementations of EU Directive (EU) 2018/1673 on combating money laundering by criminal law get stuck

Healthcare organisations implementing EU Directive (EU) 2018/1673 on combating money laundering by criminal law commonly face these challenges:

1

Protecting electronic health records (EHR) and patient data across distributed systems

2

Meeting multiple overlapping regulations (HIPAA, FDA 21 CFR, GxP, GDPR for clinical trials)

3

Securing connected medical devices and IoT endpoints in clinical environments

4

Managing third-party vendor risk across supply chains for pharmaceuticals and devices

5

Balancing rapid digital health innovation with data protection requirements

A working order for healthcare implementations

1. Assess Current State

Conduct a readiness assessment against EU Directive (EU) 2018/1673 on combating money laundering by criminal law to identify gaps specific to your healthcare environment. Our AI-powered assessment takes 5 minutes and produces a prioritised action plan.

2. Map Regulatory Overlap

Use cross-framework mapping to identify where EU Directive (EU) 2018/1673 on combating money laundering by criminal law controls satisfy other healthcare regulations. This reduces duplicate effort and accelerates compliance.

3. Implement Priority Controls

Focus on high-risk gaps first, using healthcare-specific threat intelligence to prioritise controls that address your most material risks.

4. Monitor & Improve

Establish continuous monitoring and regular reassessment cycles. Healthcare regulations evolve frequently, so compliance is an ongoing programme, not a one-time project.

Who owns EU Directive (EU) 2018/1673 on combating money laundering by criminal law in a healthcare organisation

EU Directive (EU) 2018/1673 on combating money laundering by criminal law for CISOsView guide →EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Compliance OfficersView guide →EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Risk ManagersView guide →EU Directive (EU) 2018/1673 on combating money laundering by criminal law for IT DirectorsView guide →EU Directive (EU) 2018/1673 on combating money laundering by criminal law for DPOsView guide →EU Directive (EU) 2018/1673 on combating money laundering by criminal law for AuditorsView guide →

EU Directive (EU) 2018/1673 on combating money laundering by criminal law in other sectors

EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Financial Services→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Technology→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Government→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Manufacturing→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Energy→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Retail→EU Directive (EU) 2018/1673 on combating money laundering by criminal law for Education→

Questions healthcare teams ask about EU Directive (EU) 2018/1673 on combating money laundering by criminal law

Why is EU Directive (EU) 2018/1673 on combating money laundering by criminal law important for Healthcare?
Healthcare organisations face unique compliance challenges including protecting electronic health records (ehr) and patient data across distributed systems and meeting multiple overlapping regulations (hipaa, fda 21 cfr, gxp, gdpr for clinical trials). EU Directive (EU) 2018/1673 on combating money laundering by criminal law provides a structured approach to addressing these challenges through 20 controls that can be tailored to healthcare requirements.
How do Healthcare organisations implement EU Directive (EU) 2018/1673 on combating money laundering by criminal law?
Implementation starts with a gap assessment to identify which EU Directive (EU) 2018/1673 on combating money laundering by criminal law controls are already in place and which gaps exist. Healthcare organisations should prioritise controls that address their specific regulatory context: healthcare organisations typically navigate hipaa, fda regulations, gxp requirements, and regional data protection laws simultaneously.
What are the biggest EU Directive (EU) 2018/1673 on combating money laundering by criminal law compliance challenges in Healthcare?
The primary challenges include protecting electronic health records (ehr) and patient data across distributed systems; meeting multiple overlapping regulations (hipaa, fda 21 cfr, gxp, gdpr for clinical trials); securing connected medical devices and iot endpoints in clinical environments. A structured implementation approach with clear milestones and executive sponsorship helps overcome these obstacles.
Does EU Directive (EU) 2018/1673 on combating money laundering by criminal law satisfy Healthcare regulatory requirements?
EU Directive (EU) 2018/1673 on combating money laundering by criminal law provides a strong foundation for meeting healthcare regulatory requirements particularly in European Union. However, organisations should conduct a detailed mapping between EU Directive (EU) 2018/1673 on combating money laundering by criminal law controls and their specific regulatory obligations to identify any gaps. Our compliance platform maps EU Directive (EU) 2018/1673 on combating money laundering by criminal law against other frameworks to help identify overlapping requirements.
How long does EU Directive (EU) 2018/1673 on combating money laundering by criminal law implementation take in Healthcare?
Implementation timelines vary based on organisational size, existing maturity, and scope. Most healthcare organisations achieve initial compliance within 6-12 months, with ongoing improvement cycles thereafter. Starting with a readiness assessment helps establish a realistic timeline based on your current gap profile.

How ready is your Healthcare organisation for EU Directive (EU) 2018/1673 on combating money laundering by criminal law?

Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items tailored to healthcare. Results in 5 minutes.

Get Your Readiness ReportBrowse Toolkits & Resources
Written and maintained by Gerard Blokdyk, The Art of Service.Last updated .